vimarsana.com
Home
Live Updates
Targeted Agent Improves Survival in FLT3-Positive Acute Myel
Targeted Agent Improves Survival in FLT3-Positive Acute Myel
Targeted Agent Improves Survival in FLT3-Positive Acute Myeloid Leukemia
OS, EFS improved versus historical controls with addition of midostaurin to chemotherapy
Related Keywords
Germany ,
United States ,
Fox Chase Cancer Center ,
Pennsylvania ,
Philadelphia ,
American ,
Peter Abdelmessieh ,
Charles Bankhead ,
American Society Of Hematology ,
University Hospital Ulm ,
Study Group ,
American Society ,
Medpage Today ,